Category II reportable diseases and conditions. Category II reportable diseases and conditions include:

1. (1) Acute flaccid myelitis;
2. (2) Anaplasmosis (Anaplasmaphagocytophilum);
3. (3) Arboviral encephalitis, meningitis or infection (Eastern equine, Western equine, California serogroup, St Louis, Japanese, Powassan, West Nile virus, Chikungunya, Colorado tick fever, Zika virus);
4. (4) Babesiosis (Babesiaspp);
5. (5) Campylobacteriosis (Campylobacter spp.);
6. (6) Chancroid (Haemophilusducreyi);
7. (7) Carbon monoxide poisoning;
8. (8) Chicken pox/Varicella (herpesvirus);
9. (9) Chlamydia infections (Chlamydiatrachomatis);
10. (10) Cholera (Vibriocholerae);
11. (11) Cryptosporidiosis (Cryptosporidiumparvum);
12. (12) Coccidioidomycosis (Coccidioidesspp);
13. (13) Cyclospora (Cyclosporacayetanensis);
14. (14) Dengue viral infection (flaviviruses);

15. (15) Drug resistant organisms:

    1. (a) Vancomycin-resistant Staphylococcus aureus (VRSA);
    2. (b) Carbapenemase-producing organisms;
    3. (c) Candida auris;
16. (16) Ehrlichiosis (Ehrlichia spp.);
17. (17) Giardiasis (Giardialamblia);
18. (18) Gonorrhea (Neisseriagonorrhoeae);
19. (19) Haemophilus influenzae, invasive disease;
20. (20) Hantavirus pulmonary syndrome and Hantavirus infection (Hantaviruses);
21. (21) Hemolytic uremic syndrome;
22. (22) Hepatitis, viral types A, B, and C, including all molecular Hepatitis C results;

23. (23) Human immunodeficiency virus (HIV) infection; including:

    1. (a) AIDS (StageIIIinfection);
    2. (b) CD4 counts in HIV infection persons;
    3. (c) HIV viral loads;
    4. (d) Pregnancy in HIV-infected females;
    5. (e) HIV gene sequencing;
    6. (f) HIV antiviral resistance; and
    7. (g) Confirmatory results, positive or negative, following a reactive HIV screening test;

24. (24) Influenza:

    1. (a) Laboratory-confirmed cases;
    2. (b) Influenza-associated deaths;
    3. (c) Influenza-associated hospitalizations; and
    4. (d) Weekly reports of number of rapid antigen influenza positive tests and total number tested;
25. (25) Lead, all blood levels;
26. (26) Legionellosis (Legionella spp.);
27. (27) Leprosy/Hansen's disease (Mycobacteriumleprae);
28. (28) Leptospirosis (Leptospira);
29. (29) Listeriosis (Listeriamonocytogenes);
30. (30) Lyme disease (Borreliaburgdorferi);
31. (31) Malaria (Plasmodium spp.);
32. (32) Melioidosis (Burkholderiapseudomallei);
33. (33) Mumps;
34. (34) Pertussis (Bordetellapertussis);
35. (35) Pesticide-related illness and injury, acute;
36. (36) Psittacosis (Chlamydiapsittaci);
37. (37) Q fever (Coxiellaburnetii);
38. (38) Salmonellosis (Salmonella spp.);
39. (39) Shigellosis (Shigella spp.);
40. (40) Silicosis;
41. (41) Spotted Fever Rickettsiosis (Rickettsiaspp);
42. (42) Streptococcus pneumoniae, invasive;
43. (43) Syphilis (Treponemapallidum), including primary, secondary, early latent, late latent, neurosyphilis, ocular syphilis, otosyphilis, stillbirth, and congenital;
44. (44) Tetanus (Clostridiumtetani);
45. (45) Toxic shock syndrome (Streptococcal and non-Streptococcal);
46. (46) Transmissible spongiform encephalopathies, such as Creutzfeldt-Jakob disease;
47. (47) Trichinosis (Trichinellaspiralis);
48. (48) Tuberculosis (MycobacteriumtuberculosisorMycobacteriumbovis): Latent infection in a high risk person;
49. (49) Typhoid (Salmonellatyphi); and
50. (50) Vibriosis (Vibrionaceae).

Source: 20 SDR 69, effective November 17, 1993; 23 SDR 60, effective October 31, 1996; 28 SDR 92, effective December 30, 2001; 29 SDR 87, effective December 22, 2002; 30 SDR 87, effective December 7, 2003; 31 SDR 89, effective December 27, 2004; 33 SDR 106, effective December 26, 2006; 34 SDR 179, effective December 24, 2007; 38 SDR 8, effective August 1, 2011; 39 SDR 203, effective June 10, 2013; 42 SDR 77, effective November 30, 2015 ; 42 SDR 173, effective July 1, 2016; 45 SDR 83, effective December 17, 2018; 50 SDR 12, effective August 8, 2023 .

General Authority: SDCL 34-1-17 , 34-22-9 , 34-22-12 , 34-23-13 .

Law Implemented: SDCL 34-22-9 , 34-22-12 , 34-23-2 , 34-23-13 .

Prior versions effective: 2018-12-17, 2016-07-01, 2015-11-30, 2013-06-10.